The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

House Republicans have passed a budget resolution that paves the way for President Donald Trump’s “big, beautiful bill” — and ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

Swiss pharma group Novartis has said it will expand its US manufacturing and research and development with a $23bn investment over five years, as drugmakers reconfigure their supply chains as part of ...

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...